摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-fluoro-2-(piperidin-4-yloxy)pyrimidin-4-amine hydrochloride | 1202005-99-9

中文名称
——
中文别名
——
英文名称
5-fluoro-2-(piperidin-4-yloxy)pyrimidin-4-amine hydrochloride
英文别名
——
5-fluoro-2-(piperidin-4-yloxy)pyrimidin-4-amine hydrochloride化学式
CAS
1202005-99-9
化学式
C9H13FN4O*ClH
mdl
——
分子量
248.688
InChiKey
UTUBFVDGMPDYJU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.75
  • 重原子数:
    16.0
  • 可旋转键数:
    2.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    73.06
  • 氢给体数:
    2.0
  • 氢受体数:
    5.0

反应信息

  • 作为反应物:
    描述:
    4,5,6-三氟嘧啶5-fluoro-2-(piperidin-4-yloxy)pyrimidin-4-amine hydrochlorideN,N-二异丙基乙胺 作用下, 以 正丁醇 为溶剂, 反应 1.0h, 以83%的产率得到2-[1-(5,6-Difluoropyrimidin-4-yl)piperidin-4-yl]oxy-5-fluoropyrimidin-4-amine
    参考文献:
    名称:
    O-LINKED PYRIMIDIN-4-AMINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE TO TREAT CANCER
    摘要:
    O-连接的嘧啶-4-胺基化合物,包括它们的药物组合物以及它们的使用方法。本发明的特定化合物为公式I:
    公开号:
    US20080146571A1
  • 作为产物:
    描述:
    1-butyl-3-methylimidazolium Tetrafluoroborate 在 盐酸 作用下, 以 乙醇 为溶剂, 反应 18.0h, 生成 5-fluoro-2-(piperidin-4-yloxy)pyrimidin-4-amine hydrochloride
    参考文献:
    名称:
    O-LINKED PYRIMIDIN-4-AMINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE TO TREAT CANCER
    摘要:
    O-连接的嘧啶-4-胺基化合物,包括它们的药物组合物以及它们的使用方法。本发明的特定化合物为公式I:
    公开号:
    US20080146571A1
点击查看最新优质反应信息

文献信息

  • Practical Synthesis of 5-Fluoro-2-(piperidin-4-yloxy)pyrimidin-4-amine, a Key Intermediate in the Preparation of Potent Deoxycytidine Kinase Inhibitors
    作者:Haiming Zhang、Jie Yan、Ramanaiah C. Kanamarlapudi、Wenxue Wu、Philip Keyes
    DOI:10.1021/op900060u
    日期:2009.7.17
    A practical synthesis of 5-fluoro-2-(piperidin-4-yloxy)pyrimidin-4-amine, a key intermediate in the preparation of a new class of potent deoxycytidine kinase (dCK) inhibitors, is described. The commercially available 2,4-dichloro-5-fluoropyrimidine (12) is converted in four telescoped steps to tert-butyl 4-(4-amino-5- fluoropyrimidin-2-yloxy)piperidine-1-carboxylate (6a) which upon deprotection gives 5-fluoro-2-(piperidin-4-yloxy)pyrimidin-4-amine dihydrochloride (1a) in about 68% overall yield. This process proved to be an economical alternative to a Mitsunobu-based synthesis.
  • 5-Fluorocytosine derivatives as inhibitors of deoxycytidine kinase
    作者:James E. Tarver、Theodore C. Jessop、Marianne Carlsen、David J. Augeri、Qinghong Fu、Jason P. Healy、Alexander Heim-Riether、Amy Xu、Jerry A. Taylor、Min Shen、Philip E. Keyes、S. David Kimball、Xuan-Chuan Yu、Maricar Miranda、Qingyun Liu、Jonathan C. Swaffield、Amr Nouraldeen、Alan G.E. Wilson、Rick Finch、Kanchan Jhaver、Ann Marie DiGeorge Foushee、Steve Anderson、Tamas Oravecz、Kenneth G. Carson
    DOI:10.1016/j.bmcl.2009.09.082
    日期:2009.12
    A series of potent piperidine-linked cytosine derivatives were prepared as inhibitors of deoxycytidine kinase (dCK). Compound 9h was discovered to be a potent inhibitor of dCK and shows a good combination of cellular potency and pharmacokinetic parameters. Compound 9h blocks the incorporation of radiolabeled cytosine into mouse T-cells in vitro, as well as in vivo in mice following a T-cell challenge. (C) 2009 Published by Elsevier Ltd.
查看更多